Urology · Brooklyn, NY
NPI
1366446825
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
175 Remsen St Ste 1225
Brooklyn, NY, 11201
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$256K
3,802 services
Medicare patients, 2024
480
Average age 73
Drug cost, 2024
$2.5M
3,665 prescriptions
Company payments, 2025
$677
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ivan Colon was code 36415 (venipuncture blood collection), 335 times for 225 patients. In total Ivan Colon billed 3,802 services in 110 codes, and Medicare paid $256K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 335 | 225 | $8.65 | $2,898 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 322 | 90 | $52.46 | $17K |
| 51798 Ultrasound - Nonspecific | Office | 282 | 187 | $9.64 | $2,719 |
| 99213 Office E&M - Established | Office | 271 | 208 | $70.56 | $19K |
| 51784 Neurologic | Office | 213 | 165 | $24.93 | $5,311 |
| 51741 Test - Miscellaneous | Office | 212 | 165 | $5.56 | $1,178 |
| 51729 Other Organ Systems | Office | 195 | 152 | $336.17 | $66K |
| 99214 Office E&M - Established | Office | 180 | 134 | $105.13 | $19K |
| 81002 Clinical Chemistry | Office | 168 | 126 | $3.41 | $573 |
| 80053 Clinical Chemistry | Office | 94 | 71 | $10.35 | $973 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 84 | 13 | $125.56 | $11K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 84 | 71 | $48.24 | $4,052 |
| 84403 Clinical Chemistry | Office | 79 | 66 | $25.29 | $1,998 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 70 | $14.37 | $1,120 |
| 85025 Blood Count | Office | 63 | 55 | $7.61 | $479 |
By year: 2022 $291K for 3,524 services; 2023 $312K for 4,617 services; 2024 $256K for 3,802 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 335 | 225 | $8.65 | $2,898 |
| 81002 Clinical Chemistry | 168 | 126 | $3.41 | $573 |
| 80053 Clinical Chemistry | 94 | 71 | $10.35 | $973 |
| 84403 Clinical Chemistry | 79 | 66 | $25.29 | $1,998 |
| 85025 Blood Count | 63 | 55 | $7.61 | $479 |
| 82306 Clinical Chemistry | 47 | 36 | $29.01 | $1,363 |
| 83615 Clinical Chemistry | 44 | 28 | $5.92 | $260 |
| 84550 Clinical Chemistry | 44 | 28 | $4.43 | $195 |
| 84100 Clinical Chemistry | 43 | 27 | $4.65 | $200 |
| 83735 Clinical Chemistry | 43 | 27 | $6.57 | $283 |
Medicare prescription drug claims, 2024
In 2024, the drug Ivan Colon prescribed most often to Medicare patients was Tamsulosin Hcl, with 842 prescriptions and refills. In total Ivan Colon wrote 3,665 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 842 | 2,212 | 371 | $13K |
| Gemtesa Vibegron | 391 | 447 | 98 | $204K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 370 | 708 | 119 | $4,909 |
| Finasteride Generic | 354 | 959 | 157 | $3,511 |
| Lupron Depot Leuprolide Acetate | 284 | 852 | 112 | $1.6M |
| Estradiol Generic | 266 | 494 | 99 | $12K |
| Solifenacin Succinate Generic | 200 | 364 | 55 | $15K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 194 | 401 | 55 | $3,786 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 83 | 83 | 78 | $1,922 |
| Myrbetriq Mirabegron | 72 | 94 | 21 | $40K |
| Silodosin Generic | 60 | 118 | 21 | $4,555 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 44 | 44 | 33 | $938 |
| Levofloxacin Generic | 40 | 40 | 39 | $237 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 35 | 35 | 33 | $113 |
| Xtandi Enzalutamide | 32 | 34 | Under 11 | $466K |
Brand drugs: - claims; generic drugs: 2,820 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ivan Colon $677 ($677 in general payments such as food, travel and fees) from 4 companies. The largest payer was Boston Scientific Corporation with $267.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.